McLaurin EB - Search Results

Year	Number of Results
1969	1
1978	1
1984	1
2009	1
2010	2
2012	2
2013	1
2014	2
2015	1
2019	1
2021	2
2022	1
2023	2
2024	3
2025	0

1

A randomized, vehicle-controlled, Phase 2b study of two concentrations of the TRPM8 receptor agonist AR-15512 in the treatment of dry eye disease (COMET-1).

Wirta DL, Senchyna M, Lewis AE, Evans DG, McLaurin EB, Ousler GW, Hollander DA. Wirta DL, et al. Among authors: mclaurin eb. Ocul Surf. 2022 Oct;26:166-173. doi: 10.1016/j.jtos.2022.08.003. Epub 2022 Aug 13. Ocul Surf. 2022. PMID: 35970431 Free article. Clinical Trial.

2

Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.

Bacharach J, McLaurin EB, Silverstein S, Amrane M, Garrigue JS, Ismail D, Flynn WJ; Catiolanze Phase 2 study group. Bacharach J, et al. Among authors: mclaurin eb. J Ocul Pharmacol Ther. 2024 Nov;40(9):553-561. doi: 10.1089/jop.2024.0029. Epub 2024 Aug 16. J Ocul Pharmacol Ther. 2024. PMID: 39150378 Free article. Clinical Trial.

3

Omidenepag Isopropyl in Latanoprost Low/Nonresponders With Primary Open Angle Glaucoma or Ocular Hypertension: A Phase 3, Nonrandomized, Two-Phase, Open-Label Study.

Panarelli JF, Bowden EC, Tepedino ME, Odani-Kawabata N, Pei Z, McLaurin EB, Ropo A. Panarelli JF, et al. Among authors: mclaurin eb. J Glaucoma. 2023 Dec 1;32(12):999-1005. doi: 10.1097/IJG.0000000000002321. Epub 2023 Oct 17. J Glaucoma. 2023. PMID: 37853676 Free PMC article. Clinical Trial.

4

Efficacy and Safety of the Melanocortin Pan-Agonist PL9643 in a Phase 2 Study of Patients with Dry Eye Disease.

Evans D, Kenyon K, Ousler G, Watson M, Vollmer P, McLaurin EB, Torkildsen G, Winters J, Dodd J, Jordan R, Wills ST, Spana C. Evans D, et al. Among authors: mclaurin eb. J Ocul Pharmacol Ther. 2023 Nov;39(9):600-610. doi: 10.1089/jop.2023.0056. Epub 2023 Sep 7. J Ocul Pharmacol Ther. 2023. PMID: 37677000 Free PMC article. Clinical Trial.

5

Phase 3 Randomized Study of Efficacy and Safety of a Dexamethasone Intracanalicular Insert in Patients With Allergic Conjunctivitis.

McLaurin EB, Evans D, Repke CS, Sato MA, Gomes PJ, Reilly E, Blender N, Silva FQ, Vantipalli S, Metzinger JL, Gibson A, Goldstein MH. McLaurin EB, et al. Am J Ophthalmol. 2021 Sep;229:288-300. doi: 10.1016/j.ajo.2021.03.017. Epub 2021 Mar 25. Am J Ophthalmol. 2021. PMID: 33773984 Free article. Clinical Trial.

6

Plasma Pharmacokinetic Parameters of Dexamethasone Following Administration of a Dexamethasone Intracanalicular Insert in Healthy Adults.

Blizzard C, McLaurin EB, Driscoll A, Silva FQ, Vantipalli S, Metzinger JL, Goldstein MH. Blizzard C, et al. Among authors: mclaurin eb. Clin Ophthalmol. 2021 May 18;15:2055-2061. doi: 10.2147/OPTH.S307194. eCollection 2021. Clin Ophthalmol. 2021. PMID: 34040341 Free PMC article.

7

Pilocarpine HCl 1.25% for treatment of presbyopia after laser vision correction: pooled analysis of two phase 3 randomized trials (GEMINI 1 and 2).

Lievens CW, Hom MM, McLaurin EB, Yuan J, Safyan E, Liu H. Lievens CW, et al. Among authors: mclaurin eb. J Cataract Refract Surg. 2024 Jan 1;50(1):57-63. doi: 10.1097/j.jcrs.0000000000001313. J Cataract Refract Surg. 2024. PMID: 37702453

8

Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.

Sheppard JD, Torkildsen GL, Lonsdale JD, D'Ambrosio FA Jr, McLaurin EB, Eiferman RA, Kennedy KS, Semba CP; OPUS-1 Study Group. Sheppard JD, et al. Among authors: mclaurin eb. Ophthalmology. 2014 Feb;121(2):475-83. doi: 10.1016/j.ophtha.2013.09.015. Epub 2013 Nov 26. Ophthalmology. 2014. PMID: 24289915 Clinical Trial.

9

A Randomized, Multicenter Phase 3 Clinical Trial Evaluating Intracanalicular Dexamethasone Insert for the Treatment of Allergic Conjunctivitis.

Kenyon K, McLaurin EB, Silverstein SM, Meyer JC, Anderson E, Patel RH, Gomes PJ, Reilly E, Vantipalli S, Cheung MW, Goldstein MH. Kenyon K, et al. Among authors: mclaurin eb. Clin Ophthalmol. 2024 Sep 21;18:2671-2684. doi: 10.2147/OPTH.S476419. eCollection 2024. Clin Ophthalmol. 2024. PMID: 39328900 Free PMC article. Clinical Trial.

10

Ocular itch relief with alcaftadine 0.25% versus olopatadine 0.2% in allergic conjunctivitis: pooled analysis of two multicenter randomized clinical trials.

McLaurin EB, Marsico NP, Ackerman SL, Ciolino JB, Williams JM, Villanueva L, Hollander DA. McLaurin EB, et al. Adv Ther. 2014 Oct;31(10):1059-71. doi: 10.1007/s12325-014-0155-3. Epub 2014 Sep 27. Adv Ther. 2014. PMID: 25260889 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year